Zhongqiang Guo

Hubei Key Laboratory Of Tumor Biological Behavior
Wuhan, 430072, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Spatial Confinement-Accelerated DNAzyme Nanoassembly for Demethylase Imaging and Chemoresistance Evaluation in Living Cells.

Spatial Confinement-Accelerated DNAzyme Nanoassembly for Demethylase Imaging and Chemoresistance Evaluation in Living Cells.

Journal: ACS nano

Published: June 26, 2026

Correction to: Downregulation of TRPM7 suppressed migration and invasion by regulating epithelial-mesenchymal transition in prostate cancer cells.

Correction to: Downregulation of TRPM7 suppressed migration and invasion by regulating epithelial-mesenchymal transition in prostate cancer cells.

Journal: Medical oncology (Northwood, London, England)

Published: May 30, 2025

CAPN2 promotes apalutamide resistance in metastatic hormone-sensitive prostate cancer by activating protective autophagy.

CAPN2 promotes apalutamide resistance in metastatic hormone-sensitive prostate cancer by activating protective autophagy.

Journal: Journal of translational medicine

Published: March 18, 2024

Editorial Expression of Concern: Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7.

Editorial Expression of Concern: Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7.

Journal: Molecular cancer

Published: April 26, 2023

Correction to: Downregulation of TRPM7 suppressed migration and invasion by regulating epithelial-mesenchymal transition in prostate cancer cells.

Correction to: Downregulation of TRPM7 suppressed migration and invasion by regulating epithelial-mesenchymal transition in prostate cancer cells.

Journal: Medical oncology (Northwood, London, England)

Published: September 07, 2022

Non-invasive diagnosis and surveillance of bladder cancer with driver and passenger DNA methylation in a prospective cohort study.

Non-invasive diagnosis and surveillance of bladder cancer with driver and passenger DNA methylation in a prospective cohort study.

Journal: Clinical and translational medicine

Published: May 09, 2022

Correction: Qian et al. Capsaicin Suppresses Cell Proliferation, Induces Cell Cycle Arrest and ROS Production in Bladder Cancer Cells through FOXO3a-Mediated Pathways. Molecules 2016, 21, 1406.

Correction: Qian et al. Capsaicin Suppresses Cell Proliferation, Induces Cell Cycle Arrest and ROS Production in Bladder Cancer Cells through FOXO3a-Mediated Pathways. Molecules 2016, 21, 1406.

Journal: Molecules (Basel, Switzerland)

Published: April 22, 2022

Wild-type IDH1 inhibits the tumor growth through degrading HIF-α in renal cell carcinoma.

Wild-type IDH1 inhibits the tumor growth through degrading HIF-α in renal cell carcinoma.

Journal: International journal of biological sciences

Published: October 12, 2020

The prediction value of PI-RADS v2 score in high-grade Prostate Cancer: a multicenter retrospective study.

The prediction value of PI-RADS v2 score in high-grade Prostate Cancer: a multicenter retrospective study.

Journal: International journal of medical sciences

Published: March 06, 2020

Establishing a prediction model of infection during the intravesical instillation of bladder cancer: a multicenter retrospective study.

Establishing a prediction model of infection during the intravesical instillation of bladder cancer: a multicenter retrospective study.

Journal: Journal of Cancer

Published: February 18, 2020

Prognostic value of downregulated 5-hydroxymethylcytosine expression in renal cell carcinoma: a 10 year follow-up retrospective study.

Prognostic value of downregulated 5-hydroxymethylcytosine expression in renal cell carcinoma: a 10 year follow-up retrospective study.

Journal: Journal of Cancer

Published: July 09, 2019

SB225002 inhibits prostate cancer invasion and attenuates the expression of BSP, OPN and MMP‑2.

SB225002 inhibits prostate cancer invasion and attenuates the expression of BSP, OPN and MMP‑2.

Journal: Oncology reports

Published: October 18, 2017

Showing 1-12 of 22

Last Updated: 09/26/2026